Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2002002109) USE OF GALIELLA LACTONE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2002/002109 International Application No.: PCT/EP2001/006935
Publication Date: 10.01.2002 International Filing Date: 20.06.2001
Chapter 2 Demand Filed: 08.01.2002
IPC:
A61K 31/365 (2006.01) ,C07D 307/93 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
365
Lactones
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
307
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
77
ortho- or peri-condensed with carbocyclic rings or ring systems
93
condensed with a ring other than six-membered
Applicants:
BAUMGARTEN, Jörg [DE/DE]; DE (UsOnly)
WEIDLER, Marcus [DE/DE]; DE (UsOnly)
ERKEL, Gerhard [DE/DE]; DE (UsOnly)
ANKE, Heidrun [DE/DE]; DE (UsOnly)
ANKE, Timm [DE/DE]; DE (UsOnly)
INSTITUT FÜR BIOTECHNOLOGIE UND WIRKSTOFF-FORSCHUNG E.V. [DE/DE]; Erwin-Schrödinger-Str. 56 67663 Kaiserslautern, DE (AllExceptUS)
Inventors:
BAUMGARTEN, Jörg; DE
WEIDLER, Marcus; DE
ERKEL, Gerhard; DE
ANKE, Heidrun; DE
ANKE, Timm; DE
Agent:
NOBBE, Matthias; Viering, Jentschura & Partner Centroallee 263 46047 Oberhausen, DE
Priority Data:
100 32 242.503.07.2000DE
100 47 295.825.09.2000DE
Title (EN) USE OF GALIELLA LACTONE
(FR) UTILISATION DE LACTONE DE GALIELLE
(DE) VERWENDUNG VON GALIELLA-LACTON
Abstract:
(EN) The invention relates to the use of the substance known as galiella lactone as a pharmaceutical, especially for treating inflammatory processes.
(FR) L'invention concerne l'utilisation de la substance connue sous le nom de lactone de galielle comme médicament, en particulier pour le traitement de processus inflammatoires.
(DE) Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)